LENZ

LENZ Therapeutics
LENZ

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$849.45M
EV
$656.66M
Shares Outstanding
30.10M
Beta
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$44.50
P/E 2025E
-
P/Revenue 2025E
112.30x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About LENZ Therapeutics, Inc.

gainify
LENZ

LENZ Therapeutics, Inc.

LENZ

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. T...

Sector

Healthcare

Industry

Biotechnology

CEO

Schimmelpennink, Evert

Employees

11

IPO Date

2024-03-22

Headquarters

445 Marine View Avenue, Suite 320, Del Mar, California, 92014, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.